PolyPid Ltd. was incorporated in 2008 in the State of Israel.
PolyPid Ltd. is located at 18 Hasivim Street, Petach Tikva 4959376, Israel and the fully owned subsidiary PolyPid Inc. is located at Suite 302A, 47 Maple Street, Summit, NJ 07901.
PolyPid Ltd. went public on 26th June, 2020.
PolyPid Ltd. is traded on The Nasdaq Global Market under the ticker symbol PYPD.
PolyPid Ltd. 's fiscal year ends on December 31st.
Shares of PolyPid can be purchased through a broker or stock purchase service of your preference.
No, PolyPid Ltd. does not have a direct stock purchase program.
The company has not paid any dividends to its stockholders since its inception and does not plan to pay any cash dividends in the foreseeable future.
The transfer agent and registrar for our ordinary shares is American Stock Transfer & Trust Company, LLC. You can contact our transfer agent by email at firstname.lastname@example.org and by telephone at (800) 937-5449 or (718) 921-8124.
Cooley LLP (US) and Sullivan & Worcester (Israel)
Annual Reports and other investor materials are available under the SEC Filings page of the Investors section of the corporate website. Additionally, all SEC filings can also be accessed directly from the SEC website (www.sec.gov).
You can view Polypid’s R&D plans by visiting the Pipeline section (http://www.polypid.com/pipeline) of our website.